l-2,3-二氨基丙酸的结合模式限制了工程单巴坦类似物在更大底物上的生物合成

IF 8.5 Q1 CHEMISTRY, MULTIDISCIPLINARY
Lukas Kahlert, Ketan D. Patel, Michael S. Lichstrahl, Rongfeng Li, Chengkun He, Andrew M. Gulick* and Craig A. Townsend*, 
{"title":"l-2,3-二氨基丙酸的结合模式限制了工程单巴坦类似物在更大底物上的生物合成","authors":"Lukas Kahlert,&nbsp;Ketan D. Patel,&nbsp;Michael S. Lichstrahl,&nbsp;Rongfeng Li,&nbsp;Chengkun He,&nbsp;Andrew M. Gulick* and Craig A. Townsend*,&nbsp;","doi":"10.1021/jacsau.5c0023110.1021/jacsau.5c00231","DOIUrl":null,"url":null,"abstract":"<p >The simple but essential azetidinone core of the β-lactam antibiotics is uniquely N-sulfonated in the monobactam subfamily. This feature confers both target binding specificity to inactivate bacterial cell wall biosynthesis (antibiosis) and structural differentiation to elude destruction by metallo-β-lactamases (MBLs). The recent FDA approval of Emblaveo to treat serious bacterial infections combines an established synthetic monobactam aztreonam and avibactam, which additionally blocks serine β-lactamases, to create a broadly effective antibacterial therapeutic. Here we report experiments to capture the native monobactam biosynthetic steps to the natural product sulfazecin with the aim of accessing new monobactams by reprogramming its biosynthetic machinery. In sulfazecin biosynthesis, the β-lactam ring is formed by a nonribosomal peptide synthetase SulM that incorporates <span>l</span>-2,3-diaminopropionate (Dap), which is then N-sulfonated in trans and efficiently cyclized to the fully elaborated monobactam by an unusual thioesterase (TE) domain. We describe an improved synthesis of (2<i>S</i>,3<i>R</i>)-vinylDap to support rational structure-based engineering experiments to obtain the corresponding (4<i>R</i>)-vinyl sulfazecin. While these experiments were initially based on an AlphaFold model of the adenylation domain that incorporates Dap (SulM A3), we further report high-resolution X-ray crystal structures with both the <span>l</span>-Dap substrate and an accurate analogue of the activated (3<i>R</i>)-methyl-Dap adenylate bound. The ligand-bound structures rationalize the inability of SulA3 to incorporate larger substrates. Comparisons with the structures of other diamino acid-activating adenylation domains identify alternate binding modes that may be more suitable for the production of sulfazecin analogues. The impact of these structures on the further engineering of the SulA3 domain and its relation to monobactam synthesis in the recently structurally characterized SulTE are discussed.</p>","PeriodicalId":94060,"journal":{"name":"JACS Au","volume":"5 4","pages":"1992–2003 1992–2003"},"PeriodicalIF":8.5000,"publicationDate":"2025-04-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://pubs.acs.org/doi/epdf/10.1021/jacsau.5c00231","citationCount":"0","resultStr":"{\"title\":\"l-2,3-Diaminopropionate Binding Mode of the SulM Adenylation Domain Limits Engineering Monobactam Analogue Biosynthesis with Larger Substrates\",\"authors\":\"Lukas Kahlert,&nbsp;Ketan D. Patel,&nbsp;Michael S. Lichstrahl,&nbsp;Rongfeng Li,&nbsp;Chengkun He,&nbsp;Andrew M. Gulick* and Craig A. Townsend*,&nbsp;\",\"doi\":\"10.1021/jacsau.5c0023110.1021/jacsau.5c00231\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p >The simple but essential azetidinone core of the β-lactam antibiotics is uniquely N-sulfonated in the monobactam subfamily. This feature confers both target binding specificity to inactivate bacterial cell wall biosynthesis (antibiosis) and structural differentiation to elude destruction by metallo-β-lactamases (MBLs). The recent FDA approval of Emblaveo to treat serious bacterial infections combines an established synthetic monobactam aztreonam and avibactam, which additionally blocks serine β-lactamases, to create a broadly effective antibacterial therapeutic. Here we report experiments to capture the native monobactam biosynthetic steps to the natural product sulfazecin with the aim of accessing new monobactams by reprogramming its biosynthetic machinery. In sulfazecin biosynthesis, the β-lactam ring is formed by a nonribosomal peptide synthetase SulM that incorporates <span>l</span>-2,3-diaminopropionate (Dap), which is then N-sulfonated in trans and efficiently cyclized to the fully elaborated monobactam by an unusual thioesterase (TE) domain. We describe an improved synthesis of (2<i>S</i>,3<i>R</i>)-vinylDap to support rational structure-based engineering experiments to obtain the corresponding (4<i>R</i>)-vinyl sulfazecin. While these experiments were initially based on an AlphaFold model of the adenylation domain that incorporates Dap (SulM A3), we further report high-resolution X-ray crystal structures with both the <span>l</span>-Dap substrate and an accurate analogue of the activated (3<i>R</i>)-methyl-Dap adenylate bound. The ligand-bound structures rationalize the inability of SulA3 to incorporate larger substrates. Comparisons with the structures of other diamino acid-activating adenylation domains identify alternate binding modes that may be more suitable for the production of sulfazecin analogues. The impact of these structures on the further engineering of the SulA3 domain and its relation to monobactam synthesis in the recently structurally characterized SulTE are discussed.</p>\",\"PeriodicalId\":94060,\"journal\":{\"name\":\"JACS Au\",\"volume\":\"5 4\",\"pages\":\"1992–2003 1992–2003\"},\"PeriodicalIF\":8.5000,\"publicationDate\":\"2025-04-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://pubs.acs.org/doi/epdf/10.1021/jacsau.5c00231\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"JACS Au\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://pubs.acs.org/doi/10.1021/jacsau.5c00231\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CHEMISTRY, MULTIDISCIPLINARY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"JACS Au","FirstCategoryId":"1085","ListUrlMain":"https://pubs.acs.org/doi/10.1021/jacsau.5c00231","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0

摘要

β-内酰胺类抗生素的简单但必需的氮杂二酮核心是单巴坦亚家族中唯一的n -磺化。这一特性赋予了目标结合特异性,使细菌细胞壁生物合成失活(抗生素)和结构分化,以避免金属β-内酰胺酶(MBLs)的破坏。最近FDA批准了Emblaveo用于治疗严重细菌感染,该药物结合了一种已建立的合成单巴坦氮曲南和阿维巴坦,后者可额外阻断丝氨酸β-内酰胺酶,从而创造出一种广泛有效的抗菌治疗药物。在这里,我们报告了捕获天然单巴塔菌生物合成步骤到天然产物磺胺的实验,目的是通过重新编程其生物合成机制来获得新的单巴塔菌。在磺胺生物合成中,β-内酰胺环由非核糖体肽合成酶SulM形成,该酶结合了l-2,3-二氨基丙酸(Dap),然后在反式中n -磺化,并通过一种不寻常的硫酯酶(TE)结构域有效地环化为完全合成的单巴坦。我们描述了一种改进的(2S,3R)-vinylDap的合成方法,以支持合理的基于结构的工程实验,以获得相应的(4R)-乙烯基磺胺。虽然这些实验最初是基于包含Dap (SulM A3)的腺苷化结构域的AlphaFold模型,但我们进一步报道了具有l-Dap底物和活化(3R)-甲基-Dap腺苷酸结合的精确模拟物的高分辨率x射线晶体结构。配体结合结构使SulA3无法结合更大的底物。与其他二氨基酸激活腺苷酸化结构域的结构比较,确定了可能更适合磺胺嘧啶类似物生产的替代结合模式。讨论了这些结构对SulA3结构域进一步工程的影响及其在最近结构表征的SulTE中与单巴坦合成的关系。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
l-2,3-Diaminopropionate Binding Mode of the SulM Adenylation Domain Limits Engineering Monobactam Analogue Biosynthesis with Larger Substrates

The simple but essential azetidinone core of the β-lactam antibiotics is uniquely N-sulfonated in the monobactam subfamily. This feature confers both target binding specificity to inactivate bacterial cell wall biosynthesis (antibiosis) and structural differentiation to elude destruction by metallo-β-lactamases (MBLs). The recent FDA approval of Emblaveo to treat serious bacterial infections combines an established synthetic monobactam aztreonam and avibactam, which additionally blocks serine β-lactamases, to create a broadly effective antibacterial therapeutic. Here we report experiments to capture the native monobactam biosynthetic steps to the natural product sulfazecin with the aim of accessing new monobactams by reprogramming its biosynthetic machinery. In sulfazecin biosynthesis, the β-lactam ring is formed by a nonribosomal peptide synthetase SulM that incorporates l-2,3-diaminopropionate (Dap), which is then N-sulfonated in trans and efficiently cyclized to the fully elaborated monobactam by an unusual thioesterase (TE) domain. We describe an improved synthesis of (2S,3R)-vinylDap to support rational structure-based engineering experiments to obtain the corresponding (4R)-vinyl sulfazecin. While these experiments were initially based on an AlphaFold model of the adenylation domain that incorporates Dap (SulM A3), we further report high-resolution X-ray crystal structures with both the l-Dap substrate and an accurate analogue of the activated (3R)-methyl-Dap adenylate bound. The ligand-bound structures rationalize the inability of SulA3 to incorporate larger substrates. Comparisons with the structures of other diamino acid-activating adenylation domains identify alternate binding modes that may be more suitable for the production of sulfazecin analogues. The impact of these structures on the further engineering of the SulA3 domain and its relation to monobactam synthesis in the recently structurally characterized SulTE are discussed.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
9.10
自引率
0.00%
发文量
0
审稿时长
10 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信